Inhalational nitric oxide: A selective pulmonary vasodilator for treatment of persistent pulmonary hypertension of the newborn

The Journal of Pediatrics

Volumn 123, Issue 1, 1993, Pages 76-79

  Geggel, Robert L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

AEROSOL; DRUG EFFICACY; ENDOTHELIUM CELL; HUMAN; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; VASODILATATION;

ADMINISTRATION, INHALATION; HUMAN; INFANT, NEWBORN; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; VASODILATOR AGENTS;

EID: 0027167095     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)81540-9     Document Type: Editorial

References (46)

1. “PFC” syndrome (persistence of the fetal circulation)
2. The structural basis of PPHN
3. Use of cardiotonic therapy in the management of infants with PPHN
4. Persistent pulmonary hypertension in the neonate: diagnosis and management
5. Oxygen toxicity and other ventilatory complications of treatment of infants with persistent pulmonary hypertension
6. 2, attenuates hypoxia-induced pulmonary vasoconstriction in newborn lambs
7. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation
8. Muscle relaxation in mechanically ventilated infants
9. Acute cardiopulmonary effects of pancuronium bromide in mechanically ventilated newborn infants
10. High-frequency ventilation in the neonate
11. High-frequency oscillation in the rescue of infants with persistent pulmonary hypertension
12. High-frequency jet ventilation in neonatal pulmonary hypertension
13. Effect of high-frequency ventilation on gas exchange and pulmonary vascular resistance in lambs
14. Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn
15. Use of sodium nitroprusside in neonates: efficacy and safety
16. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb
17. Extracorporeal membrane oxygenation and neonatal respiratory failure: experience from the Extracorporeal Life Support Organization
18. A prospective, multicenter, randomized study of high versus low positive end-expiratory pressure during extracorporeal membrane oxygenation
19. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
20. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
21. Vascular endothelial cells synthesize nitric oxide from l-arginine
22. Nitric oxide (NO), a new test gas for study of alveolar-capillary diffusion
23. Bronchodilator action of inhaled nitric oxide in guinea pigs
24. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide
25. Biological effects of nitrogen dioxide and nitric oxide
26. Effects of higher oxides of nitrogen on the anaesthetized dog
27. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
28. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep
29. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep
30. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension
31. Inhaled nitric oxide for the adult respiratory distress syndrome
32. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension
33. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth
34. Effects of birth-related stimuli on l-arginine-dependent pulmonary vasodilation in ovine fetus
35. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation
36. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease
37. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome
38. Inhaled nitric oxide (NO) for the treatment of pulmonary hypertension before and after cardiopulmonary bypass (CPB)
39. Nitric oxide synthesis is decreased in persistent pulmonary hypertension of the newborn
40. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
41. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
42. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
43. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
44. NIOSH recommendations for iccupational safety and health standards
45. Inhaled nitric oxide in congenital heart disease
46. Tone and responsiveness in the fetal and neonatal pulmonary circulation